Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.htct.2018.11.004
- Subjects: LEUCEMIA; HEMATOPOESE; RECIDIVA LOCAL DE NEOPLASIA; IMUNOTERAPIA; ANTICORPOS MONOCLONAIS; ANTINEOPLÁSICOS; RESULTADO DE TRATAMENTO
- Language: Inglês
- Source:
- Título: Hematology
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: TRANSFUSION AND CELL THERAPY, v. 41, n. 4, p. 356-359, 2019
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVA, Wellington Fernandes da et al. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin. Hematology, v. 41, n. 4, p. 356-359, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2018.11.004. Acesso em: 25 mar. 2026. -
APA
Silva, W. F. da, Marquez, G. L., Salim, R. C., & Rocha, V. G. (2019). Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin. Hematology, 41( 4), 356-359. doi:10.1016/j.htct.2018.11.004 -
NLM
Silva WF da, Marquez GL, Salim RC, Rocha VG. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin [Internet]. Hematology. 2019 ; 41( 4): 356-359.[citado 2026 mar. 25 ] Available from: https://doi.org/10.1016/j.htct.2018.11.004 -
Vancouver
Silva WF da, Marquez GL, Salim RC, Rocha VG. Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin [Internet]. Hematology. 2019 ; 41( 4): 356-359.[citado 2026 mar. 25 ] Available from: https://doi.org/10.1016/j.htct.2018.11.004 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
